Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-015869
Filing Date
2023-04-28
Accepted
2023-04-28 16:28:17
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A 2023_proxy_defa14a.htm DEFA14A 35690
2 GRAPHIC img265883665_0.jpg GRAPHIC 127195
3 GRAPHIC img265883665_1.jpg GRAPHIC 44888
  Complete submission text file 0000950170-23-015869.txt   263074
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40881 | Film No.: 23866952
SIC: 2834 Pharmaceutical Preparations